Idarucizumab-Praxbind, an Antidote to dabigatran: REVERSE-AD Study supriya kashyap kashyap11 Sept 2016 2:09 PM ISTStudy Highlights: A new treatment can quickly and completely reverse the effects of the blood thinner dabigatran (Pradaxa) in patients...
Genetic testing can help determine safest dose of blood thinner Anjali Nimesh Nimesh29 Sept 2017 9:45 AM ISTA new study finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer side effects, in patients...
Genetic testing helps determine safest dose of blood thinner for joint surgery patients Anjali Nimesh Nimesh26 Oct 2017 7:10 PM ISTA new five-year study of nearly 1,600 patients finds that genetic testing can help determine the safest dose of the blood thinner warfarin, with fewer...
Apixaban -A safer anticoagulant for AF patients on dialysis: Circulation Study Medha Baranwal Baranwal2 July 2018 8:20 PM ISTThe use of apixaban, an anticoagulant, in end-stage kidney disease (ESKD) patients with atrial fibrillation (AF) on dialysis, lowers the risk of major...
Apixaban safe and effective anticoagulant in cancer patients Medha Baranwal Baranwal8 Dec 2018 7:10 PM ISTTreatment with the oral drug apixaban for prevention of blood clot formation in patients undergoing cancer therapy is safe and effective, Mayo Clinic...
Blood Thinners in Heart Failure significantly reduce Heart attack Risk: Clinical trial Hina Zahid26 April 2019 7:10 PM ISTUse of Blood Thinners in patients of heart failure, coronary artery disease or AF may reduce risk of heart attack, finds a clinical trial.Blood...
Idarucizumab rapidly reverses the effect of blood thinner dabigatran : NEJM Study supriya kashyap kashyap14 July 2017 9:44 AM ISTUSA: At least 28 million prescriptions for blood thinners are filled by pharmacists yearly for the irregular heartbeat of atrial fibrillation, deep...
